References
- Palmer SC, Nistor I, Craig JC, et al. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 2013;10(4):e101436.
- Padhi D, Harris R. Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride. Clin Pharmacokinet. 2009;48:303–311.
- Harris RZ, Padhi D, Marbury TC, et al. Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily. Am J Kidney Dis. 2004;44(6):1070–1076.
- Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349–358.
- Patra CN, Routray SB. Solid lipid based delivery systems for oral delivery of drugs: a review. Asian J Pharmaceutics. 2018;12:12–23.
- Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlling drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
- Aburahma MH, Badr-Eldin SM. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv. 2014;11(12):1865–1883.
- Ahmad I, Anwar M, Akhter S, et al. Supercritical fluid technology-based trans-resveratrol SLN for long circulation and improved radio protection. J Pharm Innov. 2016;11(4):308–322.
- Porfire A, Muntean DM, Rus L, et al. A quality by design approach for the development of lyophilized liposomes with simvastatin. Saudi Pharm J. 2017;25(7):981–992.
- Ameeduzzafar QM, Alruwaili NK, Bukhari SNA, et al. BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment. J. Pharm Innov. 2020;15:1–14.
- Panigrahi KC, Patra CN, Rao MEB. Quality by design enabled development of oral self-nanoemulsifying drug delivery system of a novel calcimimetic cinacalcet HCl using a porous carrier: in vitro and in vivo characterisation. AAPS PharmSciTech. 2019;20(5):216.
- Zhang JQ, Liu J, Li XL, et al. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 2007;14(6):381–387.
- Varshosaz J, Tabbakhian M, Mohammadi MY. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J Liposome Res. 2010;20(4):286–296.
- Kathe N, Henriksen B, Chauhan H. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev Ind Pharm. 2014;40(12):1565–1575.
- Song X, Zhao Y, Wu W, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm. 2008;350(1-2):320–329.
- Negi JS, Chattopadhyay P, Sharma AK, et al. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nanoemulsification (SNE) technique. Eur J Pharm Sci. 2013;48(1-2):231–239.
- Girotra P, Singh SK, Kumar G. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. Int J Biol Macromol. 2016;85:92–101.
- Haleem RM, Salem MY, Fatahallah FA, et al. Quality in the pharmaceutical industry – a literature review. Saudi Pharm J. 2015;23:462–466.
- Arsiccio A, Pisano R. Application of the quality by design approach to the freezing step of freeze-drying: building the design space. J Pharm Sci. 2018;107(6):1586–1596.
- Zhang H, Chen W, Zhao Z, et al. Lyophilized nanosuspensions for oral bioavailability improvement of insoluble drugs: preparation, characterization and pharmacokinetic studies. J Pharm Innov. 2017;12(3):271–280.
- Gangurde PK, Ajit KBN, Kumar L. Lipid nanoparticles for effective treatment of epilepsy: a focus on brain targeting via nasal route. J Pharm Innov. 2019;14(2):91–111.
- Rocha ED, Ferreira MRS, Dos SNE, et al. Enhanced in vitro antimicrobial activity of polymyxin B coated nanostructured lipid carrier containing dexamethasone acetate. J Pharm Innov. 2020;15:1–11.
- Rahman N, Nasir M. Application of Box-Behnken design and desirability function in the optimization of Cd(II) removal from aqueous solution using poly(o-phenylenediamine)/hydrous zirconium oxide composite: equilibrium modeling, kinetic and thermodynamic studies. Environ Sci Pollut Res Int. 2018;25(26):26114–26134.
- Rohrer J, Partenhauser A, Hauptstein S, et al. Mucus permeating thiolated self-emulsifying drug delivery systems. Eur J Pharm Biopharm. 2016;98:90–97.
- Dodiya S, Chavhan S, Korde A, et al. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies. Drug Dev Ind Pharm. 2013;39(5):733–743.
- Ghaffari S, Varshosaz J, Haririan I, et al. Ciprofloxacin loaded alginate/chitosan and solid lipid nanoparticles, preparation and characterization. J Dispers Sci Technol. 2012;33(5):685–689.
- Verma S, Singh SK, Verma PRP, et al. Formulation by design of felodipine loaded liquid and solid self noanoemulsifying drug delivery systems using Box-Behnken design. Drug Dev Ind Pharm. 2014;40(10):1358–1370.
- Panigrahi KC, Jena J, Jena GK, et al. QBD-based systematic development of Bosentan SNEDDS: Formulation, characterization and pharmacokinetic assessment. J Drug Deliv Sci Technol. 2018;47:31–42.
- Hippalgaonkar K, Adelli GR, Hippalgaonkar K, et al. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther. 2013;29(2):216–228.
- Pathak K, Keshri L, Shah M. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics. Crit Rev Ther Drug Carrier Syst. 2011;28(4):357–393.
- Schmidtgen MC, Drechsler M, Lasch J, et al. Energy-filtered cryotransmission electron microscopy of liposomes prepared from human stratum corneum lipids. J Microsc. 1998;191(Pt 2):177–186.,
- Mishra A, Vuddanda PR, Singh S. Intestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: formulation design, in vitro and in vivo studies. J Nanotechnol. 2014;2014:1–12.
- Kuo YC, Chung CY. Solid lipid nanoparticles comprising internal compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir. Colloids Surf B Biointerfaces. 2011;88(2):682–690.
- Dudhipala N, Janga KY, Gorre T. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Artif Cells Nanomed Biotechnol. 2018;46(sup2):616–625.
- Dudhipala N, Janga KY. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2017;43(7):1205–1214.
- Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930–934.